GlassScriptPhysician profile
Shafi Mohamed
NPI 1346434743
$15,623.99
in general payments reported to CMS, 2019-2025
23 companies · $5,731 in 2025
The $5,731 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $782 · 2021: $141 · 2022: $234 · 2023: $4,440 · 2024: $3,872 · 2025: $5,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $11K · Food and Beverage: $1,569 · Travel and Lodging: $1,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $11,000.00 |
| Food and Beverage | $1,568.96 |
| Travel and Lodging | $1,474.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,173.76 | 2020-2025 | Davinci Xi, Da Vinci Surgical System |
| Abiomed | $545.16 | 2019-2025 | Impella |
| Angiodynamics, INC. | $504.59 | 2023-2024 | Alphavac |
| Medtronic, INC. | $221.18 | 2023 | Endurant Iis |
| Endologix LLC | $212.74 | 2019 | |
| Abbott Laboratories | $148.38 | 2019-2020 | |
| Nuwellis, INC. | $136.88 | 2022 | |
| Vifor Pharma, INC. | $109.01 | 2020 | |
| Stryker Corporation | $87.54 | 2025 | Flowtriever |
| Zimmer Biomet Holdings, INC. | $84.14 | 2025 | Sternalock 360 System |
| Medtronic Vascular, INC. | $72.44 | 2019 | |
| Edwards Lifesciences Corporation | $66.52 | 2020 | |
| Janssen Pharmaceuticals, INC | $45.84 | 2021-2022 | |
| Ethicon US, LLC | $40.19 | 2025 | Evarrest |
| Chiesi USA, INC. | $37.87 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $27.66 | 2020 | |
| Livanova USA, INC. | $25.02 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.31 | 2019 | |
| Boston Scientific Corporation | $16.90 | 2021 | |
| Haemonetics Corporation | $16.51 | 2023 | |
| Baxter Healthcare | $13.83 | 2019 | |
| Olympus America INC. | $13.06 | 2019 | |
| Elutia, INC. | $6.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shafi Mohamed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.